IMS Health, a provider of prescription-drug data, agreed to sell itself to TPG Capital and Canada Pension Plan’s investment board for $5.2bn in what is the biggest leveraged buy-out this year.

The deal, which drew interest from a number of rival private-equity firms, is the latest sign that improving financial markets have started to ease access to capital, rebuild corporate share prices and repair confidence shattered by last year’s credit crisis.